Boston Partners
STJ

Boston Partners’s St Jude Medical STJ Stock Holding History

Boston Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,014,649
Closed -$162M – 825
2016
Q4 		$162M Sell
2,014,649
-2,482,862
-55% -$197M 0.21% 145
2016
Q3 		$359M Sell
4,497,511
-2,486,892
-36% -$201M 0.5% 62
2016
Q2 		$545M Buy
6,984,403
+2,311,074
+49% +$165M 0.79% 27
2016
Q1 		$257M Buy
4,673,329
+1,102,538
+31% +$60.1M 0.38% 88
2015
Q4 		$221M Buy
3,570,791
+874,706
+32% +$55.2M 0.32% 107
2015
Q3 		$170M Buy
2,696,085
+451,137
+20% +$32.2M 0.26% 126
2015
Q2 		$164M Buy
2,244,948
+237,324
+12% +$17.1M 0.24% 131
2015
Q1 		$131M Buy
2,007,624
+301,369
+18% +$20M 0.2% 147
2014
Q4 		$111M Buy
+1,706,255
New +$110M 0.17% 147

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boston Partners's STJ Position: Q1 2017 in Review

Boston Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,014,649 shares — an estimated $162M sold.

Boston Partners first reported a position in STJ in Q4 2014 and held it in 9 quarters. The position peaked at $545M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Boston Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Boston Partners sold 2,014,649 St Jude Medical shares in Q1 2017, an estimated $162M.
  • Boston Partners first reported a position in St Jude Medical in Q4 2014 and held it in 9 quarters.
  • Boston Partners's St Jude Medical position peaked at $545M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Boston Partners's 13F filing for Q1 2017, filed 3 May 2017.